← Leaderboards
Roberta B. Ness
Magee-Women'S Hospital Of Upmc
$10,750,719
Attributed
$10,750,719
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$10,750,719 · 8
AHRQ$0 · 1
By mechanism
R01$9,478,796 · 5
R21$447,304 · 1
T32$431,992 · 1
P01$365,663 · 1
M01$26,964 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemaleHuman SubjectInterviewClinical ResearchWomen'S HealthSexually Transmitted DiseasesPelvic Inflammatory DiseaseClinical TrialsEpidemiologyGrowth FactorChlamydia TrachomatisChlamydiaceaeNeisseria GonorrhoeaeChlamydial DiseaseInflammationPreeclampsiaBiomedical FacilityCase HistoryHeat Shock ProteinsSelf CareGonorrheaPatient Oriented ResearchData ManagementData Collection
Grant awards (31)
Fetal Growth Restriction & Maternal Cardiovascular Risk$529,122
R01 · FY2009 · HL · contact PI
Fetal Growth Restriction & Maternal Cardiovascular Risk$553,874
R01 · FY2008 · HL · contact PI
Predoctoral Training Program in Reproductive, Perinatal & Pediatric Epidemiology$215,996
T32 · FY2008 · HD · contact PI
Fetal Growth Restriction & Maternal Cardiovascular Risk$640,550
R01 · FY2007 · HL · contact PI
Inflammation and Ovarian Cancer$569,950
R01 · FY2007 · CA · contact PI
Predoctoral Training Program in Reproductive, Perinatal & Pediatric Epidemiology$215,996
T32 · FY2007 · HD · contact PI
Fetal Growth Restriction & Maternal Cardiovascular Risk$648,528
R01 · FY2006 · HL · contact PI
Inflammation and Ovarian Cancer$6,857
R01 · FY2006 · CA · contact PI
Fetal Growth Restriction &Maternal Cardiovascular Risk$587,564
R01 · FY2005 · HL
Inflammation and Ovarian Cancer$566,387
R01 · FY2005 · CA
Inflammation and Ovarian Cancer$544,140
R01 · FY2004 · CA
Douching, Vaginal Microbiology and PID Study$26,964
M01 · FY2004 · RR
HOME SCREENING FOR CHLAMYDIA SURVEILLANCE$0
R01 · FY2004 · HS
DOUCHING, VAGINAL MICROBIOLOGY, AND PID$627,932
R01 · FY2003 · AI
Inflammation and Ovarian Cancer$516,671
R01 · FY2003 · CA
Effectiveness of Outpatient Treatment of PID$396,949
R01 · FY2003 · AI
HOME SCREENING FOR CHLAMYDIA SURVEILLANCE$0
R01 · FY2003 · HS
Effectiveness of Outpatient Treatment of PID$667,738
R01 · FY2002 · AI
DOUCHING, VAGINAL MICROBIOLOGY, AND PID$632,178
R01 · FY2002 · AI
HOME SCREENING FOR CHLAMYDIA SURVEILLANCE$0
R01 · FY2002 · HS
CORE--Data and clinical$0
P01 · FY2002 · HD
Effectiveness of Outpatient Treatment of PID$721,255
R01 · FY2001 · AI
DOUCHING, VAGINAL MICROBIOLOGY, AND PID$633,775
R01 · FY2001 · AI
CORE--DATA AND CLINICAL PREDICTION$176,978
P01 · FY2001 · HD
HOME SCREENING FOR CHLAMYDIA SURVEILLANCE$0
R01 · FY2001 · HS
CORE--DATA AND CLINICAL PREDICTION$0
P01 · FY2001 · HD
DOUCHING, VAGINAL MICROBIOLOGY, AND PID$635,326
R01 · FY2000 · AI
EFFECTIVENESS OF OUTPATIENT TREATMENT OF PID$447,304
R21 · FY2000 · AI
CORE--DATA AND CLINICAL PREDICTION$188,685
P01 · FY2000 · HD
HOME SCREENING FOR CHLAMYDIA SURVEILLANCE$0
R01 · FY2000 · HS
CORE--DATA AND CLINICAL PREDICTION$0
P01 · FY2000 · HD